Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
asymptomatic
ataxia
ataxia telangiectasia
ataxia, cerebellar
biologic markers
cerebellar ataxia, autosomal recessive
cerebellar ataxia, hereditary
cerebellar atrophy, primary
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS tumors
chemotherapy, CNS treatment and complications with
controversies in neurology
dysarthria
dysdiadochokinesia
dysmetria
electromyogram
eye movement, disorders of
Friedreich's ataxia
gait disorder
gene
gene mutation
genetic neurologic disorders
genetic testing
glioma
glioma, low-grade
hypotonia
imbalance
incoordination
leukoencephalopathy
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
molecular genetics
molecular markers
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, negative
myelomalacia
neoplasm, primary intracerebral
neoplasm, primary of CNS
neoplasm, primary of CNS-survival
neoplasm, primary of CNS-treatment of
nerve conduction studies
neurologic disease, diagnoses of
polymerase chain reaction
prognosis
radiation therapy, CNS treatment and complications with
review article
saccadic eye movements, abnormal
seizure
staggering
tandem gait, ataxic
temozolomide
treatment of neurologic disorder
tremor
tremor, cerebellar
tremor, intention
vitamin E deficiency
walking, difficulty with
white matter disease
workup
Showing articles 200 to 250 of 755 << Previous Next >>

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

High-Resolution Diffusion Tensor Imaging in the Substantia Nigra of De Novo Parkinson Disease
Neurol 72:1378-1384,1374, Vaillancourt,D.E.,et al, 2009

Detection of Human Herpesvirus-6 in Cerebrospinal Fluid of Patients with Encephalitis
Ann Neurol 65:257-267,235, Yao,K.,et al, 2009

Diagnosis and New Treatment in Muscle Channelopathies
JNNP 80:360-365, Meola,G.,et al, 2009

CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009

Positron Emission Tomography in Diagnosis of Visual Variant Alzheimer Disease
J Neuro-Ophthalmol 29:149-150, Finelli,P.F., 2009

Neurofibromatosis Type 2
Lancet 373:1974-1986, Astagiri,A.R.,et al, 2009

Clinical Spectrum of Ataxia-Telangiectasia in Adulthood
Neurol 73:430-437, Verhagen,M.M.M.,et al, 2009

Sarcoidosis
BMJ 339:620-625, Dempsey,O.,et al, 2009

Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009

Akinetopsia in the Posterior Cortical Variant of Alzheimer Disease
Neurol 73:731-732, Tsai,P. &Mendez,M.F., 2009

Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging
JAMA 302:2565-2572, 2593, Lieb,W.,et al, 2009

Pittsburg Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
Arch Neurol 66:1469-1475, Morris,J.,et al, 2009

Ganglionic Acetylcholine Receptor Autoantibody: Oncological, Neurological, and Serological Accompaniments
Arch Neurol 66:735-741, McKeon,A.,et al, 2009

Clinical and Mutational Spectrum of Neurofibromatosis Type 1-Like Syndrome
JAMA 302:2111-2118, 2150, 2170, Messian,L.,et al, 2009

A 23-Year-Old Man With Seizures and Visual Deficit
Neurol 70:73-78, Boustany,R.-M.,et al, 2008

Functional Imaging in Parkinson Disease
Neurol 70:1478-1488, Nandhagopal,R.,et al, 2008

SOX1 Antibodies Are Markers of Paraneoplastic Lambert-Eaton Myasthenic Syndrome
Neurol 70:924-928, Sabater,L.,et al, 2008

NMO-IgG Predicts the Outcome of Recurrent Optic Neuritis
Neurol 70:2197-2200, Matiello,M.,et al, 2008

Serum Uric Acid and Clinical Progression in Parkinson Disease: Potential Biomarker for Nigrostriatal Failure
Arch Neurol 65:698-699, Schiess,M. &Oh,I., 2008

Spinal Muscular Atrophy
Lancet 371:2120-2133, Lunn,M.R. &Wang,C.H., 2008

Anti-Ma and Anti-Ta Associated Paraneoplastic Neurological Syndromes: 22 Newly Diagnosed Patients and Review of Previous Cases
JNNP 79:767-773,742, Hoffmann,L.A.,et al, 2008

Biochemical Markers in Persons With Preclinical Familial Alzheimer Disease
Neurol 71:85-92,78, Ringman,J.M.,et al., 2008

Diagnosis and Etiology of Congenital Muscular Dystrophy
Neurol 71:312-321,308, Peat,R.A.,et al., 2008

Tuberous Sclerosis
Lancet 372:657-658, Curatolo,P.,et al., 2008

Assessment of �-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography with Carbon 11-Labeled Pittsburgh Compound B
Arch Neurol 65:1304-1309,1281, Leinonen,V.,et al, 2008

A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008

A 24-Year-Old Woman with Intractable Seizures: Review of Surgery for Epilepsy
JAMA 300:2527-2538,2568, Schomer,D.I. &Black,P.M., 2008

Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol 65:1604-1611, Cilia,R.,et al, 2008

Tau Forms in CSF as a Reliable Biomarker for Progressive Supranuclear Palsy
Neurol 71:1796-1803, Borroni,B.,et al, 2008

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008

Disease-Modifying Therapies for Alzheimer Disease: Challenges to Early Intervention
Neurol 69:1622-1634, Cummings,J.L.,et al, 2007

Parkinson Disease, 10 Years After Its Genetic Revolution: Multiple Clues to a Complex Disorder
Neurol 69:2093-2104, Klein,C. &Schlossmacher,M.G., 2007

Imaging of Amyloid Burden and Distribution in Cerebral Amyloid Angiopathy
Ann Neurol 62:229-234, Johnson,K.A.,et al, 2007

Prognosis of Children With Partial Epilepsy: MRI and Serial 18FDG-Pet
Neurol 68:665-659, Gaillard,W.D.,et al, 2007

Brain Glucose Supply and The Syndrome of Infantile Neuroglycopenia
Arch Neurol 64:507-513, Pascual,J.M.,et al, 2007

The Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin for the Prevention of Venous Thromboembolism After Acute Ischaemic Stroke (PREVAIL Study): An Open-Label Randomised Comparison
Lancet 369:1347-1355, Sherman,D.G.,et al, 2007

Clinicopath Conf., Severe Microangiopathy of Diabetic Vasculopathy with Multiple Cerebral Infarcts
NEJM 357:164-173, Case Study 21-2007, 2007

Whipples Disease
NEJM 356:55-66, Fenollar,F.,et al, 2007

Detection of CSF 14-3-3 Protein in Guillain-Barr Syndrome
Neurol 67:2211-2216, Bersano,A.,et al, 2006

Tuberculosis Meningitis Mimics Malignancy Like Lesion in Fluroine-18-FDG PET Scan and Gallium Scan
Ann Nucl Med Sci 19:275-278, Chang,W.-D.,et al, 2006

The Woman Who Needed a Pet
Surv Ophthalmol 51:592-595, Atchison,M.,et al, 2006

Detection of Unknown Primary Tumor in a Patient with Cerebellar Metastasis Using FDG PET-CT: Case Report
No Shinkei Geka 34:1027-1032, Ishiguro,T.,et al, 2006

Whole-Body MRI and PET-CT in the Management of Cancer Patients
Eur Radiol 16:1216-1225, Schmidt,G.P.,et al, 2006

Phenotypic Spectrum Associated with Mutations of the Mitochondrial Polymerase y Gene
Brain 129:1674-1684, Horvath, R.,et al, 2006

Mitochondrial DNA Polymerase-y and Human Disease
Hum Mol Genet 15:R244-R252, Hudson, G.,et al, 2006

Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia
Arch Neurol 63:144-146,146, Rikkert,M.G.M.O.,et al, 2006

Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006

Clinicopath Conf, Charcot-Marie-Tooth Disease Type 2, with Aides Pupil and a Mutation in MPZ Gene
NEJM 354:2584-2592, Case 18-2006, 2006

Early Clinical Signs and Imaging Findings in Gerstmann-Straussler-Scheinker Syndrome (Pro102Leu)
Neurol 66:1672-1678, Arata,H.,et al, 2006



Showing articles 200 to 250 of 755 << Previous Next >>